ELF1 and prostate cancer: ELF1 possesses relatively few mutations within this prostate cancer dataset (0.2% samples with ELF1 mutation); however, prostate tumors have a high rate of ELF1 deletions (~15% deep deletion and ~27% shallow deletion).